{
    "fund_name": "Xtrackers MSCI USA Swap UCITS ETF",
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Swap-based replication",
        "Counterparty risk exposure"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via swap agreements to track the MSCI USA Index, which introduces counterparty risk and complexity beyond physical replication. The KIID explicitly mentions derivative usage and counterparty risk, stating that if a swap counterparty fails, investors may suffer losses. The fund's risk level is classified as 6 (highest), indicating significant potential for volatility and loss. The presence of swap agreements and the associated risks make this a complex instrument under MiFID II, as it requires investors to understand the implications of counterparty risk and the mechanics of synthetic replication.",
    "confidence": 90,
    "risk_level": 6,
    "counterparty_risk": true,
    "underlying_assets": "US large and mid-cap equities (via swap exposure)",
    "benchmark_complexity": "Standard equity index (MSCI USA), but synthetic replication adds complexity",
    "liquidity_risk": "Moderate (depends on swap counterparty liquidity and collateral management)",
    "cost_structure": "Simple (0.07% ongoing charge, no performance fee)",
    "counter_argument": "The ETF tracks a well-known, liquid equity index and does not use leverage or inverse strategies. However, the synthetic replication method and counterparty risk exposure override these factors, as MiFID II explicitly flags swap-based ETFs as complex due to the additional risks involved.",
    "final_reasoning": "The use of swap agreements for replication introduces complexity that requires investors to understand counterparty risk, collateral management, and the mechanics of synthetic replication, which are not present in physically replicated ETFs. This aligns with MiFID II's definition of complex instruments."
}